TMCnet News
U.S. Patents Awarded to Inventors in New Jersey (July 28)(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., July 28 -- The following federal patents were awarded to inventors in New Jersey. *** FMC Assigned Patent ALEXANDRIA, Va., July 28 -- FMC, Philadelphia, has been assigned a patent (8,227,493) developed by four co-inventors for dispersible pesticidal compositions. The co-inventors are Hong Liu, Pennington, N.J., Robin Dexter, Yardley, Pa., Timothy Martin, Ringoes, N.J., and Craig Martin, Morrisville, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Soluble granule pesticidal compositions comprise Flonicamid, a dispersant, and a wetting agent are disclosed." The patent application was filed on April 13, 2005 (11/578,005). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,493&OS=8,227,493&RS=8,227,493 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Aeton Medical Assigned Patent ALEXANDRIA, Va., July 28 -- Aeton Medical, Spring House, Pa., has been assigned a patent (8,226,654) developed by Roger S. Ranck, Ambler, Pa., Robert S. Kramer, Cherry Hill, N.J., and Anatoli Krivoruk, Philadelphia, for a trocar-tipped drill bit. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A drill bit comprising a trocar tip on an end of a fluted portion is disclosed. The trocar tip may configured to cut through relatively hard bone. The drill bit may also have a fluted portion for cutting through softer bone." The patent application was filed on Dec. 4, 2008 (12/328,310). The full-text of the patent can be found at http://patft1.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,226,654.PN.&OS=PN/8,226,654&RS=PN/8,226,654 Written by Shabnam Sheikh; edited by Jaya Anand. *** Ethicon Assigned Patent ALEXANDRIA, Va., July 28 -- Ethicon, Somerville, N.J., has been assigned a patent (8,226,684) developed by Jesse G. Nawrocki, Annandale, N.J., David C. Lindh Sr., Flemington, N.J., and Robert A. Rousseau, Ottsville, Pa., for "surgical sutures having collapsible tissue anchoring protrusions and methods therefor." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A surgical suture includes a shaft having a leading end, a trailing end, and an outer surface extending between the leading and trailing ends. The surgical suture includes a plurality of flexible protrusions extending from the shaft, and a lumen extending between the leading and trailing ends of the shaft. The shaft includes a plurality of openings formed in the outer surface thereof that are in communication with the lumen. The shaft includes a first axial opening at the leading end thereof in communication with the lumen and a second axial opening at the trailing end thereof in communication with the lumen. A flowable material may be disposed in the lumen. After the surgical suture is implanted, the flowable material is adapted to pass from the lumen and through the plurality of openings in the outer surface of the shaft for contacting tissue surrounding the suture." The patent application was filed on Dec. 22, 2008 (12/340,829). The full-text of the patent can be found at http://patft1.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,226,684.PN.&OS=PN/8,226,684&RS=PN/8,226,684 Written by Shabnam Sheikh; edited by Jaya Anand. *** PTC Therapeutics Assigned Patent ALEXANDRIA, Va., July 28 -- PTC Therapeutics, South Plainfield, N.J., has been assigned a patent (8,227,494) developed by five co-inventors for "pharmaceutical compositions of 1,2,4-oxadiazole benzoic acid and their use for the treatment of disease." The co-inventors are Gary Mitchell Karp, Princeton Junction, N.J., Seongwoo Hwang, Edison, N.J., Guangming Chen, Bridgewater, N.J., Neil Gregory Almstead, Princeton, N.J., and Young-Choon Moon, Belle Mead, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith." The patent application was filed on March 8, 2010 (12/719,443). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,494&OS=8,227,494&RS=8,227,494 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** IlluminOss Medical Assigned Patent ALEXANDRIA, Va., July 28 -- IlluminOss Medical, East Providence, R.I., has been assigned a patent (8,226,659) developed by four co-inventors for an "internal bone fixation system with integrated mixer." The co-inventors are Robert A. Rabiner, Tiverton, R.I., Daniel E. Rabiner, Tiverton, R.I., Raoul I. Rabiner, Perth Amboy, N.J., and Leo L. Basta, Providence, R.I. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Systems and methods for repairing a weakened or fractured bone are disclosed herein. A system for repairing a fractured bone includes a delivery catheter having an elongated shaft with a proximal end, a distal end, and a longitudinal axis therebetween, wherein the delivery catheter has an inner void for passage of bone cement components and an inner lumen for passage of a mixing element; an internal bone fixation device releasably engaging the distal end of the delivery catheter, wherein the internal bone fixation device moves from a first compact state to a second expanded state when the bone cement components are delivered to the internal bone fixation device and mixed within the internal bone fixation device; and a spinning mechanism engaged to a rotatable shaft, wherein the spinning mechanism is inserted into the internal bone fixation device." The patent application was filed on Nov. 22, 2011 (13/302,227). The full-text of the patent can be found at http://patft1.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,226,659.PN.&OS=PN/8,226,659&RS=PN/8,226,659 Written by Shabnam Sheikh; edited by Jaya Anand. *** Air Products and Chemicals Assigned Patent ALEXANDRIA, Va., July 28 -- Air Products and Chemicals, Allentown, Pa., has been assigned a patent (8,227,395) developed by four co-inventors for "process solutions containing surfactants." The co-inventors are Peng Zhang, Hillsdale, N.J., Danielle Megan King Curzi, San Francisco, Eugene Joseph Karwacki Jr., Orefield, Pa., and Leslie Cox Barber, Cave Creek, Ariz. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Process solutions comprising one or more surfactants are used to reduce the number of defects in the manufacture of semiconductor devices. In certain preferred embodiments, the process solution of the present invention may reduce post-development defects such as pattern collapse when employed as a rinse solution either during or after the development of the patterned photoresist layer. Also disclosed is a method for reducing the number of pattern collapse defects on a plurality of photoresist coated substrates employing the process solution of the present invention." The patent application was filed on July 29, 2010 (12/846,369). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,395&OS=8,227,395&RS=8,227,395 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Purdue Pharma Assigned Patent ALEXANDRIA, Va., July 28 -- Purdue Pharma, Stamford, Conn., has been assigned a patent (8,227,467) developed by Donald J. Kyle, Newtown, N.J., Qun Sun, Princeton, N.J., and Laykea Tafesse, Robinsville, N.J., for "therapeutic agents useful for treating pain." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A compound of formula: ##STR00001## wherein Ar.sup.1, Ar.sup.2, V, X, R.sub.3, R.sub.4, and m are as disclosed herein or a pharmaceutically acceptable salt thereof (a "Cyclo(hetero)alkenyl Compound"); compositions comprising an effective amount of a Cyclo(hetero)alkenyl Compound; and methods for treating or preventing, e.g., pain, UI, an ulcer, IBD, or IBS in an animal, comprising administering to an animal in need thereof an effective amount of a Cyclo(hetero)alkenyl Compound are disclosed herein." The patent application was filed on Feb. 16, 2010 (12/706,571). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,467&OS=8,227,467&RS=8,227,467 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Johnson & Johnson Consumer Assigned Patent ALEXANDRIA, Va., July 28 -- Johnson & Johnson Consumer, Skilman, N.J., has been assigned a patent (8,227,393) developed by Michael J. Fevola, Belle Mead, N.J., for "compositions comprising a polyglyceryl nonionic surfactant and a zwitterionic surfactant." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided are compositions comprising a polyglyceryl nonionic surfactant, a zwitterionic surfactant, an organic acid preservative, a non-sulfate anionic surfactant and water, wherein the composition is substantially free of ethoxylated materials and has a pH of about 5.4 or less, and uses thereof. Also provided are compositions comprising a polyglyceryl nonionic surfactant, a zwitterionic surfactant, an organic acid preservative, and water, wherein the composition is substantially free of ethoxylated materials, substantially free of sulfated anionic surfactants, and has a pH of about 5.4 or less, and uses thereof." The patent application was filed on Dec. 21, 2010 (12/974,268). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,393&OS=8,227,393&RS=8,227,393 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Exxonmobil Research and Engineering Assigned Patent ALEXANDRIA, Va., July 28 -- Exxonmobil Research and Engineering, Annandale, N.J., has been assigned a patent (8,227,392) developed by four co-inventors for "base stocks and lubricant blends containing poly-alpha olefins." The co-inventors are Margaret M. Wu, Skillman, N.J., Ernestine W. Hill, Piscataway, N.J., Liehpao Oscar Farng, Lawrenceville, N.J., and Andrew Jackson, Pennington, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "This disclosure relates to substantially atactic polymers of at least one of propylene, 1-butene or 1-pentene, processes for making such polymers and compositions including the polymers. The polymers may be used as lubricants or may be combined with low viscosity base stocks to form lubricants. The polymers may be made in the presence of a metallocene catalyst with a non-coordinating anion activator and optionally with hydrogen." The patent application was filed on May 13, 2008 (12/152,223). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,392&OS=8,227,392&RS=8,227,392 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Neurotez Assigned Patent ALEXANDRIA, Va., July 28 -- Neurotez, Bridgewater, N.J., has been assigned a patent (8,227,408) developed by Nikolaos Tezapsidis, West Orange, N.J., for "leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to methods for treating, preventing, or diagnosing the pathology of progressive cognitive disorders resulting from accumulation of an amyloid peptide, in particular, Alzheimer's disease, Down's syndrome and cerebral amyloid angiopathy, in mammalian subjects using a composition comprising therapeutically effective amount of a leptin, leptin mimic, leptin derivative, leptin agonist, or AMP-dependent protein kinase activator, alone, or in combination with, one or more lipolytic/antilipogenic compounds. It further relates to methods for improving cognitive function using a composition comprising a therapeutically effective amount of leptin, a leptin mimic, a leptin derivative, an AMP-dependent protein kinase activator, a leptin agonist, a leptin blocker, a mimic of a leptin blocker, a leptin antagonist, an AMP-dependent protein kinase inhibitor; or a pharmaceutically acceptable salt thereof." The patent application was filed on Sept. 6, 2006 (11/516,224). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,408&OS=8,227,408&RS=8,227,408 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Hoffmann-La Roche Assigned Patent for Isoxazoles ALEXANDRIA, Va., July 28 -- Hoffmann-La Roche, Nutley, N.J., has been assigned a patent (8,227,461) developed by Roland Jakob-Roetne, Inzlingen, Germany, Matthew C. Lucas, Verona, N.J., and Andrew Thomas, Binningen, Switzerland, for isoxazoles. The abstract of the patent published by the U.S. Patent and Trademark Office states: " The present invention is concerned with novel isoxazole derivatives of formula I ##STR00001## wherein X, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are as described herein, as well as pharmaceutically acceptable salts and esters thereof. The active compounds of the present invention have affinity and selectivity for GABA A .alpha.5 receptor. Further the present invention is concerned with the manufacture of the active compounds of formula I, pharmaceutical compositions containing them and their use as pharmaceuticals." The patent application was filed on April 23, 2010 (12/766,202). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,461&OS=8,227,461&RS=8,227,461 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Salix Pharmaceuticals Assigned Patent ALEXANDRIA, Va., July 28 -- Salix Pharmaceuticals, Raleigh, N.C., has been assigned a patent (8,227,482) developed by seven co-inventors for "forms of rifaximin and uses thereof." The co-inventors are Stephan D. Parent, West Lafayette, Ind., Lisa Lynn McQueen, West Lafayette, Ind., Patricia Andres, West Lafayette, Ind., Paul Schields, West Lafayette, Ind., Yiduo Wu, New Brunswick, N.J., Fei Ding, Overland Park, Kan., and Jared Peters Smit, Lafayette, Ind. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Embodiments relate to Rifaximin polymorphic, salt, and hydrate forms, methods of producing polymorphic forms and to their use in medicinal preparations and to therapeutic methods using them." The patent application was filed on March 29, 2012 (13/434,766). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,482&OS=8,227,482&RS=8,227,482 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Bristol-Myers Squibb Assigned Patent ALEXANDRIA, Va., July 28 -- Bristol-Myers Squibb, Princeton, N.J., has been assigned a patent (8,227,420) developed by five co-inventors for a "method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID." The co-inventors are Robert Cohen, Newtown, Pa., Suzette Carr, Hopewell, N.J., David Hagerty, Cardiff by the Sea, Calif., Robert James Peach, San Diego, and Jean-Claude Becker, Princeton, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to compositions and methods for treating immune system diseases such as rheumatic disease, by administering to a subject soluble CTLA4 molecules that block endogenous B7 molecules from binding their ligands, alone, or in conjunction with other agents including Disease Modifying Anti-Rheumatic Drugs (DMARDs)." The patent application was filed on March 9, 2010 (12/720,064). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,420&OS=8,227,420&RS=8,227,420 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** DJO Assigned Patent ALEXANDRIA, Va., July 28 -- DJO, Vista, Calif., has been assigned a patent (8,226,585) developed by Erez Pick, Roslyn Heights, N.Y., Fabian McCarthy Jr., Basking Ridge, N.J., and Michael Pinzur, Highland Park, Ill., for a "brace having inflatable support." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The systems and methods provide or use a brace for patient's limb that includes, among other things, a non-inflatable, rigid, lower housing for supporting the sole of a patient's foot, and an inflatable load-bearing upper housing that is affixed to the lower housing. The brace may be adjustable and configured to be fitted to patients having limbs of differing sizes, to allow the patient to obtain a more closely fitted brace." The patent application was filed on Jan. 23, 2006 (11/338,164). The full-text of the patent can be found at http://patft1.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,226,585.PN.&OS=PN/8,226,585&RS=PN/8,226,585 Written by Shabnam Sheikh; edited by Jaya Anand. *** New Jersey Institute of Technology Assigned Patent ALEXANDRIA, Va., July 28 -- New Jersey Institute of Technology, Newark, N.J., has been assigned a patent (8,227,258) developed by Timothy N. Chang, Montville, N.J., and Qiong Shen, Kearny, N.J,, for a "delivery and sensing of metered amounts of liquid materials." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A liquid delivery apparatus is provided for depositing liquid materials onto prescribed areas. The apparatus includes a sensing and delivery pin and a photo sensor. The apparatus is sized to deliver a droplet of liquid material to the surface of a target area without coming into contact with the target surface. The apparatus is also capable of drawing geometric features, such as lines and grids of liquid material. The photo sensor measures the intensity of light during a processing cycle. Measured reflected-light intensity can be compared in real-time to a reference curve which is based on test process cycles representing the light intensity expected when the process proceeds in the preferred fashion to produce a normal spot having an expected droplet size. The light intensity measurements can also be fitted with a mathematical function such as an asymmetric double sigmoidal curve." The patent application was filed on Feb. 11, 2009 (12/369,295). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,258&OS=8,227,258&RS=8,227,258 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Becton, Dickinson and Co. Assigned Patent for Safety Blood Collection Holder ALEXANDRIA, Va., July 28 -- Becton, Dickinson and Co., Franklin Lakes, N.J., has been assigned a patent (8,226,576) developed by Kirk D. Swenson, North Caldwell, N.J., and James C. Schneider, Wayne, N.J., for a "safety blood collection holder." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is a holder assembly having a holder housing, collar and safety shield. The safety shield is pivotably attached to the collar. The collar is receiving within a recess defined by the annular skirt and needle receiving port of the holder housing. The collar and attached safety shield may thus be rotated about the holder housing and an attached needle assembly, thereby allowing a user to freely position the safety shield during needle insertion and preventing the dislocation of safety shield from the holder housing." The patent application was filed on Feb. 25, 2004 (10/786,725). The full-text of the patent can be found at http://patft1.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,226,576.PN.&OS=PN/8,226,576&RS=PN/8,226,576 Written by Shabnam Sheikh; edited by Jaya Anand. *** Unigene Laboratories Assigned Patent ALEXANDRIA, Va., July 28 -- Unigene Laboratories, Boonton, N.J., has been assigned a patent (8,227,241) developed by four co-inventors for a "bacterial host cell for the direct expression of peptides." The co-inventors are Nozer M. Mehta, Randolph, N.J., Angelo P. Consalvo, Monroe, N.Y., Martha V.L. Ray, Nutley, N.J., and Christopher P. Meenan, Lincoln Park, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Expression systems are disclosed for the direct expression of peptide products into the culture media where genetically engineered host cells are grown. High yield was achieved with a special selection of hosts, and/or fermentation processes which include careful control of cell growth rate, and use of an inducer during growth phase. Special universal cloning vectors are provided for the preparation of expression vectors which include control regions having multiple promoters linked operably with coding regions encoding a signal peptide upstream from a coding region encoding the peptide of interest. Multiple transcription cassettes are also used to increase yield. The production of amidated peptides using the expression systems is also disclosed." The patent application was filed on March 9, 2005 (11/076,260). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,241&OS=8,227,241&RS=8,227,241 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Janssen Biotech, Applied Molecular Evolution Assigned Patent ALEXANDRIA, Va., July 28 -- Janssen Biotech, Horsham, Pa., and Applied Molecular Evolution, San Diego, have been assigned a patent (8,226,611) developed by fifteen co-inventors for "anti-IL-6 antibodies, compositions, methods and uses." The co-inventors are Yan Chen, Wayne, Pa., Debra Gardner, Bear, Del., David M. Knight, Berwyn, Pa., Michael W. Lark, Devon, Pa., Bailin Liang, Gilbertsville, Pa., David J. Shealy, Downingtown, Pa., Xiao-Yu R. Song, West Chester, Pa., Vedrana Stojanovic-Susulic, Princeton Junction, N.J., Raymond W. Sweet, Bryn Mawr, Pa., Susan H. Tam, Boothwyn, Pa., Sheng-Jiun Wu, Broomall, Pa., Jing Yang, Ambler, Pa., David Matthew Marquis, Encinitas, Calif., Eric Michael Smith, San Diego, and Alain Philippe Vasserot, Carlsbad, Calif. The abstract of the patent published by the U.S. Patent and Trademark Office states: "An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices." The patent application was filed on October 27, 2011 (13/283,177). The full-text of the patent can be found at http://patft1.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,226,611.PN.&OS=PN/8,226,611&RS=PN/8,226,611 Written by Shabnam Sheikh; edited by Jaya Anand. *** Alpharma Assigned Patent ALEXANDRIA, Va., July 28 -- Alpharma, Wilmington, Del., has been assigned a patent (8,227,235) developed by James Skinner, Sevierville, Tenn., and Doug Rupp, Newton, N.J., for "compositions and methods for controlling diseases in animals." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed herein are compositions for the treatment of a disease in an animal including yeast extract of Saccharomyces cerevisiae, Bacillus licheniformis or Bacillus subtilis spores, and a carrier. Also included are animal feed compositions including the composition for the prevention, control and/or treatment of a disease in an animal and an animal's food/feed. The compositions are useful to prevent, control, and treat diseases such as necrotic enteritis in poultry when used in combination with an anticoccidal ionophore or coccidiosis vaccine." The patent application was filed on Sept. 21, 2009 (12/586,359). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,235&OS=8,227,235&RS=8,227,235 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Becton, Dickinson and Co. Assigned Patent ALEXANDRIA, Va., July 28 -- Becton, Dickinson and Co., Franklin Lakes, N.J., has been assigned a patent (8,226,616) developed by Robert B. Odell, Franklin Lakes, N.J., Lawrence J. Zach, Columbus, Neb., and Alex S. Wallace, Mahwah, N.J., for a syringe assembly. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A syringe assembly comprises a syringe barrel having an elongated body defining a chamber for retaining fluid, an open proximal end, a distal end and a frusto-conically shaped tip extending from the distal end and having a passageway therethrough in fluid communication with the chamber. The chamber has an inside diameter of at least 13.5 mm. A stopper is in fluid-tight engagement inside the barrel. An elongated plunger rod extends proximally from the stopper through the open proximal end of the barrel. A flange is positioned at the proximal end of the plunger rod. The flange is shaped and positioned to limit the distal motion of the plunger rod in the barrel by contacting the proximal end of the barrel. A tip cap is releasably connected to the tip for sealing the passageway and the chamber contains injectable liquid." The patent application was filed on May 19, 2010 (12/782,787). The full-text of the patent can be found at http://patft1.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,226,616.PN.&OS=PN/8,226,616&RS=PN/8,226,616 Written by Shabnam Sheikh; edited by Jaya Anand. *** E.I. du Pont de Nemours Assigned Patent for Adhesion Promoting Cleaner Solution ALEXANDRIA, Va., July 28 -- E.I. du Pont de Nemours, Wilmington, Del., has been assigned a patent (8,227,038) developed by Patrick Henry Corcoran, Cherry Hill, N.J., for an "adhesion promoting cleaner solution." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to an adhesion promoting cleaner solution for producing and adherent coating on a resinous substrate. The adhesion promoting cleaning solution comprises a telechelic diol in a carrier liquid such as an organic solvent. Also disclosed is a process of using the adhesion promoting cleaner solution to produce an adherent coating on a resinous substrate." The patent application was filed on Jan. 11, 2008 (12/523,006). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,038.PN.&OS=PN/8,227,038&RS=PN/8,227,038 Written by Kusum Sangma; edited by Anand Kumar. *** TFH Publications Assigned Patent ALEXANDRIA, Va., July 28 -- TFH Publications, Neptune City, N.J., has been assigned a patent (8,227,007) developed by Glen S. Axelrod, Colts Neck, N.J., and Ajay Gajria, Monmouth Junction, N.J., for a "direct melt processing of resins." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to an animal chew including a resin and a method of direct injection molding the animal chew using a modified screw. The screw may incorporate, for example, additional flights or a larger transition zone. Additionally, the particle size of the resin may be less than 2000 microns." The patent application was filed on Oct. 14, 2005 (11/251,261). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,227,007.PN.&OS=PN/8,227,007&RS=PN/8,227,007 Written by Kusum Sangma; edited by Anand Kumar. For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; [email protected]; http://targetednews.com. -1094804 (c) 2012 Targeted News Service |